Do Analysts Expect GW Pharmaceuticals PLC- ADR (GWPH) Stock to Rise Next Year?

Thursday, July 2, 2020 3:12 PM | InvestorsObserver Analysts

InvestorsObserver is giving GW Pharmaceuticals PLC- ADR (GWPH) an Analyst Rating Rank of 79, meaning GWPH is ranked higher by analysts than 79% of stocks. The average projection by analysts for GWPH is $180.615 over the next 12 months and analyst’s classify the stock as a Strong Buy

Overall Score - 4.9
Wall Street analysts are rating GWPH a Strong Buy today. Find out what this means to you and get the rest of the rankings on GWPH!

Why are Analyst Ratings Important?

Fundamental research of the underlying health of a company can be an extremely useful resource when making investment decisions. Analysts observe growth prospects and forecasted earnings of companies to gain a comprehensive view of particular industries. This data allows traders to react before numbers are officially reported.

Investors Observer takes the ratings from these analysts and percentile ranks those aveages. This allows you to compare stocks extensively and in more detail than the common buy/hold/sell ratings.

What's Happening With GW Pharmaceuticals PLC- ADR Stock Today?

GW Pharmaceuticals PLC- ADR (GWPH) stock has fallen -0.26% while the S&P 500 has gained 1.48% as of 3:05 PM on Thursday, Jul 2. GWPH has fallen -$0.32 from the previous closing price of $126.19 on volume of 173,859 shares. Over the past year the S&P 500 is higher by 5.55% while GWPH has fallen -28.39%. GWPH earned $1.03 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 121.91.

Share this article:

Related Companies

Upgrade to Premium and Analyze Stocks Like a Pro

50% Off All Subscriptions
InvestorsObserver Premium
InvestorsObserver Premium
InvestorsObserver Premium
Save up to 65% with annual

InvestorsObserver Premium

$ 20.75 $ 10.38 /month
$249 $124.50 billed annually

You May Also Like

Related Articles

Is it Time to Dump Synlogic Inc (SYBX) Stock After it Is Up 5.80% in a Week?

Is Rubius Therapeutics Inc (RUBY) a Stock to Watch This Week?

What is the Market's View on RedHill Biopharma Ltd (RDHL) Stock's Price and Volume Trends

Is it Time to Dump Vaxcyte Inc (PCVX) Stock After it Has Gained 10.68% in a Week?

Should You Buy Kaleido Biosciences Inc (KLDO) Stock After it Has Risen 21.73% in a Week?

Is it Time to Dump IRIDEX Corporation (IRIX) Stock After it Has Gained 24.64% in a Week?

Related Companies